# Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis

> **NCT00152412** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 30 (—)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Levocetirizine oral solution

## Key facts

- **NCT ID:** NCT00152412
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 30 (—)
- **Last updated:** 2014-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152412, "Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00152412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*